← Back to Search

Procedure

ActivSight for Colorectal Cancer

N/A
Waitlist Available
Research Sponsored by Activ Surgical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days
Awards & highlights

Study Summary

This trial is a prospective, single-center, feasibility study with two sequential cohorts.

Who is the study for?
Adults (18+) undergoing specific laparoscopic surgeries like gastric sleeve, bypass, or cholecystectomy can join this trial. They must be able to understand and consent to the study's procedures and have no severe allergies or conditions that would exclude them.Check my eligibility
What is being tested?
The ActivSightTM system is being tested for its ability to provide real-time visualization of blood flow during surgery. It aims to improve outcomes in intestinal anastomoses and bariatric surgery by comparing it with traditional methods.See study design
What are the potential side effects?
Since ActivSightTM is a visual aid used during surgery rather than a drug, it may not have direct side effects. However, risks could include potential complications from incorrect surgical decisions based on the device's imaging.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of Adverse Events in 28 days following use of ActivSightTM
Latency of display of ActivSightTM.
Preparation time of ActivSightTM.
+4 more
Secondary outcome measures
Biliary tract structure
Ability of ActivSightTM to display blood vessels.
Ability of ActivSightTM to display perfusion.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ActivSight GroupExperimental Treatment1 Intervention
Patients undergoing intestinal anastomoses (colorectal and bariatric) with ActivSight (n=52) Patients undergoing cholecystectomy with ActivSight (n=28)

Find a Location

Who is running the clinical trial?

University at BuffaloOTHER
131 Previous Clinical Trials
98,892 Total Patients Enrolled
7 Trials studying Obesity
509 Patients Enrolled for Obesity
Ohio State UniversityOTHER
827 Previous Clinical Trials
502,684 Total Patients Enrolled
24 Trials studying Obesity
4,041 Patients Enrolled for Obesity
Activ SurgicalLead Sponsor
2 Previous Clinical Trials
190 Total Patients Enrolled

Media Library

ActivSightTM (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04633512 — N/A
Obesity Research Study Groups: ActivSight Group
Obesity Clinical Trial 2023: ActivSightTM Highlights & Side Effects. Trial Name: NCT04633512 — N/A
ActivSightTM (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04633512 — N/A
Obesity Patient Testimony for trial: Trial Name: NCT04633512 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research still actively seeking participants?

"The information hosted on clinicaltrials.gov indicates that this trial is no longer actively recruiting participants; the first posting was made November 17th 2020, and it has not been updated since April 29th 2021. Nevertheless, 884 different medical studies are still accepting patient enrolment at this time."

Answered by AI

Who else is applying?

What state do they live in?
New York
Texas
How old are they?
65+
What site did they apply to?
Kaleida Health, University of Buffalo
Memorial Hermann Sugar Land Hospital
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
0
2

Why did patients apply to this trial?

I received this email about trials for morbidly obese. I have health issues that could change if I could lose weight.
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

Yes does this study offer some kind of a device implai?
PatientReceived 2+ prior treatments
~11 spots leftby Jan 2025